Literature DB >> 21328297

Interventions to enhance return-to-work for cancer patients.

Angela Gem de Boer1, Taina Taskila, Sietske J Tamminga, Monique Hw Frings-Dresen, Michael Feuerstein, Jos H Verbeek.   

Abstract

BACKGROUND: Cancer survivors are 1.4 times more likely to be unemployed than healthy people. It is therefore important to provide cancer patients with programmes to support the return-to-work process.
OBJECTIVES: To evaluate the effectiveness of interventions aimed at enhancing return-to-work in cancer patients. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL, in The Cochrane Library Issue 2, 2010), MEDLINE, EMBASE, CINAHL, OSH-ROM, PsycINFO, DARE, ClinicalTrials.gov, Trialregister.nl and Controlled-trials.com to February 2010, reference lists of included articles and selected reviews, and contacted authors of relevant articles. SELECTION CRITERIA: Randomised controlled trials (RCTs) and controlled before-after studies (CBAs) of the effectiveness of psychological, vocational, physical, medical or multidisciplinary interventions enhancing return-to-work in cancer patients. The primary outcome was return-to-work measured as either return-to-work rate or sick leave duration. Secondary outcome was quality of life. DATA COLLECTION AND ANALYSIS: Two authors independently selected trials, assessed the risk of bias and extracted data. We pooled studies with sufficient data, judged to be clinically homogeneous in different comparisons. We assessed the overall quality of the evidence for each comparison using the GRADE approach. MAIN
RESULTS: Fourteen articles reporting 14 RCTs and 4 CBAs were included. These studies involved a total of 1652 participants. Results indicated low quality evidence of similar return-to-work rates for psychological interventions compared to care as usual (odds ratio (OR) = 2.32, 95% confidence interval (CI) 0.94 to 5.71). No vocational interventions were retrieved. Very low evidence suggested that physical training was not more effective than care as usual on improving return-to-work (OR = 1.20, 95% CI 0.32 to 4.54). Eight RCTs on medical interventions showed low quality evidence that functioning conserving approaches had similar return-to-work rates as more radical treatments (OR = 1.53, 95% CI 0.95 to 2.45). Moderate quality evidence showed multidisciplinary interventions involving physical, psychological and vocational components led to higher return-to-work rates than care as usual (OR = 1.87, 95% CI 1.07 to 3.27). No differences in the effect of psychological, physical, medical or multidisciplinary interventions compared to care as usual were found on quality of life outcomes. AUTHORS'
CONCLUSIONS: Moderate quality evidence showed that employed patients with cancer experience return-to-work benefits from multidisciplinary interventions compared to care as usual. More high quality RCTs aimed at enhancing return-to-work in cancer patients are needed.

Entities:  

Mesh:

Year:  2011        PMID: 21328297     DOI: 10.1002/14651858.CD007569.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  47 in total

1.  Cancer and Employment Issues: Perspectives from Cancer Patient Navigators.

Authors:  Robin C Vanderpool; Helen Nichols; Elizabeth F Hoffler; Jennifer E Swanberg
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

2.  Long-term workforce participation patterns following head and neck cancer.

Authors:  Alison Pearce; Aileen Timmons; Eleanor O'Sullivan; Pamela Gallagher; Rachael Gooberman-Hill; Audrey Alforque Thomas; Michal Molcho; Phyllis Butow; Linda Sharp
Journal:  J Cancer Surviv       Date:  2014-07-25       Impact factor: 4.442

3.  Returning to work following curative chemotherapy: a qualitative study of return to work barriers and preferences for intervention.

Authors:  Vikki Knott; Stephanie Zrim; E Michael Shanahan; Peter Anastassiadis; Sharon Lawn; Ganessan Kichenadasse; Shawgi Sukumaran; Christos Karapetis; Bogda Koczwara
Journal:  Support Care Cancer       Date:  2014-07-29       Impact factor: 3.603

4.  Outcomes across the return-to-work process in PC survivors attending a rehabilitation measure-results from a prospective study.

Authors:  Anneke Ullrich; Hilke M Rath; Ullrich Otto; Christa Kerschgens; Martin Raida; Christa Hagen-Aukamp; Corinna Bergelt
Journal:  Support Care Cancer       Date:  2017-07-11       Impact factor: 3.603

5.  Physical exercise and return to work: cancer survivors' experiences.

Authors:  Iris F Groeneveld; Angela G E M de Boer; Monique H W Frings-Dresen
Journal:  J Cancer Surviv       Date:  2013-02-27       Impact factor: 4.442

Review 6.  Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work.

Authors:  Mary Stergiou-Kita; Alisa Grigorovich; Victrine Tseung; Elizabeth Milosevic; Debbie Hebert; Stephanie Phan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2014-07-04       Impact factor: 4.442

7.  A controlled cohort study of long-term income in colorectal cancer patients.

Authors:  Beate Hauglann; Jūratė Saltytė Benth; Sophie D Fosså; Kjell M Tveit; Alv A Dahl
Journal:  Support Care Cancer       Date:  2014-05-13       Impact factor: 3.603

Review 8.  Vocational rehabilitation for enhancing return-to-work in workers with traumatic upper limb injuries.

Authors:  Wen-Hsuan Hou; Ching-Chi Chi; Heng-Lien Lo; Yun-Yun Chou; Ken N Kuo; Hung-Yi Chuang
Journal:  Cochrane Database Syst Rev       Date:  2017-12-06

9.  Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer.

Authors:  Reshma Jagsi; Sarah T Hawley; Paul Abrahamse; Yun Li; Nancy K Janz; Jennifer J Griggs; Cathy Bradley; John J Graff; Ann Hamilton; Steven J Katz
Journal:  Cancer       Date:  2014-04-28       Impact factor: 6.860

10.  Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors.

Authors:  Alison Pearce; Bianca Tomalin; Billingsley Kaambwa; Nicole Horevoorts; Saskia Duijts; Floortje Mols; Lonneke van de Poll-Franse; Bogda Koczwara
Journal:  J Cancer Surviv       Date:  2018-10-24       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.